Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-eluting Balloons: Experience from Central India
Author(s): Ajinkya Mahorkar , Virag Mahorkar , Uday Mahorkar , et al Added: 2 months ago

Intervention

Prevention & Chronic Conditions
The QUADRIC Study
Author(s): Wei Juan Lim , David Yong Tat Wei , Yuen Han Lim , et al Added: 2 months ago

Intervention

Prevention & Chronic Conditions
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 7 months ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 7 months ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Intervention

Vascular Disease and Surgery
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 1 year ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
PCI Patient Outcomes With Different DES
Author(s): Jonathan Ong Wei Sheng , Muhammad Bin Idu Jion , Keh Yann Shan , et al Added: 2 months ago

Intervention
Balloon-expandable versus Self-expanding Valves
Author(s): Jie Jun Wong , Eugene Gan , Fei Gao , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
View from the Thoraxcenter: EuroPCR 25 Wrap Up
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 2 days ago
Explore the Top Trials from EuroPCR 25 with Insights from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at EuroPCR.In this comprehensive EuroPCR review, interventional experts examine the most significant trials, providing valuable insights into their impact on current practices… View more

Intervention
SUCCESS PTA: 12-Month Data from SELUTION SLR™ DEB
Author(s): Michael Lichtenberg Added: 1 month ago
12 Month Outcomes of the SUCCESS PTA Study show consistent safety and effectiveness in claudicant and CLTI patients when using the SELUTION SLR™ drug eluting balloon.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the SUCCESS PTA study, a prospective, observational global registry evaluating the SELUTION SLR DEB in 723 patients across Europe, Asia and… View more

Intervention

Vascular Disease and Surgery
EuroPCR 24: The CAGEFREE II Trial
Author(s): Ling Tao Added: 1 year ago
EuroPCR 2024 — Investigator, Dr Ling Tao joins us to discuss the findings from the CAGEFREE II trial.Compared to drug-eluting stents, drug-coated balloons are associated with faster vessel healing and reduced thrombotic burden, therefore patients treated with DCBs require a less intensive antiplatelet therapy. CAGEFREE II investigated the effectiveness and safety of a tailored one-month DAPT… View more

Intervention